25th May 2016 07:58
LONDON (Alliance News) - Early cancer detection technology company Oncimmune Holdings PLC on Wednesday said it has signed three new US distribution deals for its EarlyCDT-Lung test.
Oncimmune, which floated in London last week, said all three agreements have been signed with national and regional distributors. It brings the total number of US deals in place to seven.
No financial details were disclosed.
"We continue to explore further opportunities in the US and other regions and are in talks with several other distributors," said Geoffrey Hamilton-Fairley, Oncimmune's chief executive.
Shares in Oncimmune were up 1.3% to 132.25 pence.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
Oncimmune